Moreover, this aligns with the role of PI3K-AKT signaling, for example, invoking PI3K activity in breast cancer cells serves to activate FAK (focal adhesion kinase), increasing the levels of αvβ3 integrin and promoting cisplatin resistance 68. This evidence concerns the gene AKT1 and breast cancer.